.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In Illinois, Remedi has demonstrated a notable upward trajectory in the Concentrates category. Starting at rank 21 in August 2025, the brand improved to rank 16 by November 2025, reflecting a significant boost in sales. This positive movement indicates a strengthening market presence and growing consumer preference. Conversely, in Massachusetts, Remedi's performance in the Concentrates category has been less consistent. After dropping out of the top 30 in September and October, the brand managed to re-enter the rankings at position 31 in November. This fluctuation suggests challenges in maintaining a stable foothold in the Massachusetts market.
Within the Tincture & Sublingual category in Illinois, Remedi has consistently remained among the top performers, maintaining a rank of 3rd place for most of the observed period, with a slight dip to 4th place in October. This stability highlights Remedi's strong brand loyalty and effectiveness in this category. The absence of Remedi in the top 30 rankings for the Tincture & Sublingual category in Massachusetts suggests a need for strategic realignment to capture market share. These insights underscore the varying dynamics across different states and categories, offering a glimpse into Remedi's performance landscape.
Competitive Landscape
In the Illinois concentrates market, Remedi has shown a notable upward trajectory in recent months, climbing from a rank of 22 in October 2025 to 16 in November 2025. This improvement is significant considering that Remedi was not even in the top 20 as recently as August 2025. This upward movement in rank coincides with a substantial increase in sales, suggesting a positive reception from consumers. In comparison, UpNorth Humboldt maintained a stable position at rank 14 from September to November 2025, while Redemption Botanicals saw a slight improvement, moving from rank 17 in October to 15 in November 2025. Meanwhile, FloraCal Farms experienced a decline, dropping from rank 13 in August to 17 in November 2025. Remedi's rise in rank and sales indicates a strengthening market presence, potentially positioning it as a more formidable competitor in the Illinois concentrates category.
Notable Products
In November 2025, Indica Relief RSO Syringe (0.5g) maintained its position as the top-performing product for Remedi, with sales reaching an impressive 2332 units. Indica Rest RSO Dropper (0.5g) consistently held the second rank throughout the months, showing strong sales performance. Indica Rest RSO Syringe (0.5g) remained steady at the third position, indicating stable demand. The CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) climbed from fifth to fourth place, showcasing a slight increase in popularity. OG Kush Breath RSO (1g) entered the rankings at the fifth position, marking its presence in the competitive landscape.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
